首页/数据集/Supplemental Material: Dupilumab’s Impact on Sleep Disruptions in Atopic Dermatitis: A Systematic Review and Meta-Analysis

Supplemental Material: Dupilumab’s Impact on Sleep Disruptions in Atopic Dermatitis: A Systematic Review and Meta-Analysis

Mendeley Data2026-04-09 收录

特应性皮炎治疗

睡眠障碍干预

数据链接：

https://data.mendeley.com/datasets/795dsfy2vk/1 数据链接链接失效反馈

官方服务：

资源简介：

Supplemental Material: Dupilumab’s Impact on Sleep Disruptions in Atopic Dermatitis: A Systematic Review and Meta-Analysis

应用场景：

相关数据集

Data Availability Statement.docx

特应性皮炎治疗

微生物定植干预

The aim of the study was to investigate whether repeated whole-body cryotherapy treatments would have an impact on the colonization of Staphylococcus aureus in individuals with AD.

DataCite Commons2024-04-09 更新330

Table S1 - Supplemental material for Reported Pregnancy Outcomes in Women With Severe Atopic Dermatitis Treated With Dupilumab: A Systematic Review

妊娠期药物安全

特应性皮炎治疗

Supplemental material, Table S1, for Reported Pregnancy Outcomes in Women With Severe Atopic Dermatitis Treated With Dupilumab: A Systematic Review by Edgar Akuffo-Addo, Mathew N. Nicholas and Perla L

DataCite Commons2024-08-28 更新150

Table_3_The efficacy and safety of IL-13 inhibitors in atopic dermatitis: A systematic review and meta-analysis.docx

特应性皮炎治疗

IL-23抑制剂疗效

BackgroundSeveral clinical trials have evaluated the efficacy and safety of interleukin-13 (IL-13) with lebrikizumab and tralokinumab in patients with moderate to severe atopic dermatitis (AD). Howeve

NIAID Data Ecosystem60

Table8_Anti-inflammatory and immunomodulatory effects of polysaccharide extracted from Wuguchong (maggot) on 2,4-dinitrochlorobenzene-induced atopic dermatitis in mice.XLSX

特应性皮炎治疗

免疫调节药物

Atopic dermatitis (AD) is an inflammatory, heterogeneous, chronic skin disorder characterized by recurrent eczematous lesions and intense pruritus, and the pathophysiology mechanism of AD is known for

NIAID Data Ecosystem180

Oral Administration of p -Hydroxycinnamic Acid Attenuates Atopic Dermatitis by Downregulating Th1 and Th2 Cytokine Production and Keratinocyte Activation

特应性皮炎治疗

免疫调控机制

Atopic dermatitis (AD) is a complex disease that is caused by various factors, including environmental change, genetic defects, and immune imbalance. We previously showed that p-hydroxycinnamic acid (

NIAID Data Ecosystem70